Oral Abstract Session:
182a. Late Breaker Oral Abstracts
Saturday, October 22, 2011: 5:15 PM-7:15 PM
Room: 156ABC

Learning Objectives:


Target Audience: Academicians

Tracks: Adult ID, Pediatric ID, HIV, Investigative ID

Moderator:  Barbara D. Alexander, MD, FIDSA, Duke University


5:15 PM
Origins of the Causative Agent of the German HUS Outbreak: Towards Real-time, Whole genome based Molecular Epidemiology
Matthew Waldor, MD/PhD ; David A. Rasko, PhD ; Dale Webster, PhD ; Jason W. Sahl, PhD ; Ali Bashir, PhD ; Ellen Paxinos, Ph.D. ; Robert Sebra, Ph.D. ; Chen-Shan Chin, Ph. D ; Aaron Klammer, Ph.D. ; Paul Peluso, Ph.D ; Andrew Kasarskis, Ph.D ; Susana Wang, B. S. ; John Eid, Ph.D. ; David Rank, Ph.D ; Julia Redman, B.S. ; Susan R. Steyert, PhD ; Carsten Struve, Ph.D. ; Karen A. Krogfelt, Ph.D. ; James Nataro, MD, PhD ; Eric Schadt, PhD

5:30 PM
Financial Impact of an Imported Measles Outbreak on Public and Private Sectors
Karyn Leniek, MD, MPH ; Dagmar Vitek, MD, MPH ; Ilene Risk, MPA ; Mary Hill, MPH ; Valoree Vernon, MPH ; Rouett Abouzelof, RN, MSN, CIC ; Carrie L. Byington, MD ; Krow Ampofo, MD ; Andrew Pavia, MD, FIDSA

5:45 PM
Large Measles Outbreak in a High School in Canada: Lower than Expected Vaccine Efficacy in Two-dose Recipients and Higher Risk With Younger Age at First Dose
Gaston De Serres, MD, PhD ; Nicole Boulianne, RN, M.Sc ; Fannie Defay, M.Sc ; Nicholas Brousseau, MD ; Mélanie Benoît, B.Sc ; Julio C. Soto, M.D, Ph.D. ; Sylvie Lacoursière, MD, B.Pharm ; Fernand Guillemette, MD

6:00 PM
Largest Measles Outbreak in the Americas since 2000: Quebec Ongoing Epidemic
Philippe Belanger, M.Sc. ; France Markowski, B.Sc. ; Monique Landry, MD ; Bruno Turmel, MD ; Gaston De Serres, MD, PhD ; Nicole Boulianne, RN, M.Sc ; Horacio Arruda, MD ; Marlène Mercier, M.Sc.

6:15 PM
Epidemiology of measles in the United States in 2011
Huong McLean, PHD, MPH ; Albert Barskey, BA, MPH ; Preeta Kutty, MD ; Susan Redd, BA ; Jennifer Rota, BS, MPH ; Paul Rota, PhD ; William Bellini, PhD ; Gregory Armstrong, MD ; Gregory S. Wallace, MD, MS, MPH

6:30 PM
A Randomized, Double-Blind, Placebo (PCB) Controlled Study of Nitazoxanide (NTZ) in Adults and Adolescents with Acute Uncomplicated Influenza
Jean-Francois Rossignol, MD, FRCPath, PhD, FRSC ; Sreedhar Samudrala, MD ; Melanie Hoppers, MD ; Jason Haffizulla, MD ; Harvey Resnick, MD ; Aaron Hartman, MD ; Stefan Comhaire ; Maria Carrion, MD ; Matthew Bardin, PharmD, BCPS

6:45 PM
Daily Chlorhexidine Gluconate (CHG) Bathing Reduces Bacteremia in Critically Ill Children: Result from a Multicenter, Cluster Randomized, Controlled, Crossover Trial
Aaron Milstone, MD, MHS ; Alexis Elward, MD, MPH ; Xiaoyan Song, PhD, MBBS ; Danielle Zerr, MD, MPH ; Rachel Orscheln, MD ; Kathleen Speck, MPH ; Daniel Obeng, MB MSc ; Nick Reich, PhD ; Susan Coffin, MD, MPH ; Trish Perl, MD, MSc, FIDSA

7:00 PM
Boceprevir plus peginterferon/ribavirin for the treatment of HCV/HIV co-infected patients: Interim On-Treatment Results
Mark Sulkowski, MD ; S Pol ; Curtis Cooper, MD ; H Fainboim ; Jihad Slim, MD ; Antonio Rivero ; Seth Thompson ; Wayne Greaves ; Janice Wahl ; Josep Mallolas

CME Credits:

ACPE Credits:

ACPE Number:


B. D. Alexander, None

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.